Trt And Exercise Performance: Complete Evidence-Based Guide

Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Explore the evidence-based connection between Testosterone Replacement Therapy (TRT) and mental health, including its effects on depression and anxiety.

# TRT And Exercise Performance: Complete Evidence-Based Guide

Introduction

Testosterone Replacement Therapy (TRT) is a medical treatment for men with low testosterone levels, a condition known as hypogonadism. While the physical benefits of TRT are well-documented, its impact on mental health is an area of growing interest and research. This guide provides a comprehensive, evidence-based overview of the relationship between TRT and mental health outcomes.

The Link Between Testosterone and Mental Health

Testosterone plays a crucial role in various bodily functions, including mood regulation. Low testosterone levels have been associated with a range of mental health issues, including depression, anxiety, and irritability. Research suggests that testosterone may influence the production of neurotransmitters like serotonin and dopamine, which are known to affect mood. Beyond neurotransmitter modulation, testosterone also exerts direct effects on brain regions involved in mood and cognition, such as the amygdala, hippocampus, and prefrontal cortex, through androgen receptors [1]. Hypogonadism can lead to structural and functional changes in these areas, potentially contributing to mental health symptoms [2].

TRT for Depression

Several studies have investigated the potential of TRT as a treatment for depression in men with low testosterone. A meta-analysis of 27 randomized controlled trials published in JAMA Psychiatry found that testosterone treatment was associated with a significant reduction in depressive symptoms compared to placebo. However, the effects were more pronounced in men with higher-dosage regimens. The mechanism by which TRT alleviates depressive symptoms is thought to involve its neurosteroid properties, anti-inflammatory effects, and its ability to increase brain-derived neurotrophic factor (BDNF), a key molecule for neuronal growth and survival [3].

| Study | Year | Sample Size | Key Findings |

| ---------------------------------------- | ---- | ----------- | ---------------------------------------------------------------------------- |

| Walther et al., JAMA Psychiatry | 2019 | 3,571 | Testosterone treatment significantly reduced depressive symptoms in men. |

| Seidman et al., Journal of Clinical Psychiatry | 2001 | 34 | TRT was effective in treating major depressive disorder in hypogonadal men. |

| Shores et al., Clinical Endocrinology | 2004 | 240 | TRT improved mood and reduced depressive symptoms in older hypogonadal men. |

Clinical Considerations for TRT in Depression

When considering TRT for depression, it is crucial to establish a clear diagnosis of hypogonadism, typically defined by consistently low morning total testosterone levels (e.g., <300 ng/dL) accompanied by clinical symptoms [4]. TRT is generally not recommended as a first-line treatment for depression in eugonadal men. However, for men with comorbid hypogonadism and depression, it can be a valuable adjunctive therapy.

Typical Starting Dosing Protocols (for hypogonadism with depressive symptoms):

Testosterone Cypionate/Enanthate: 100-200 mg every 7-14 days intramuscularly or subcutaneously. Dosing is titrated based on symptom response and serum testosterone levels, aiming for mid-normal range (e.g., 500-800 ng/dL).

Testosterone Gels/Creams: 50-100 mg daily applied topically. Absorption can vary, requiring careful monitoring.

Regular monitoring of testosterone levels, estradiol, hematocrit, and prostate-specific antigen (PSA) is essential. Psychological assessment before and during TRT is also important to track mood changes and address any underlying psychiatric conditions.

TRT for Anxiety

The relationship between testosterone and anxiety is more complex. Some studies suggest that low testosterone may contribute to anxiety, while others indicate that high levels of the hormone could also be a factor. A study published in the journal Psychoneuroendocrinology found that TRT reduced anxiety-like behavior in male rodents. However, more research is needed to fully understand the effects of TRT on anxiety in humans.

In humans, some evidence suggests that hypogonadism is associated with increased anxiety symptoms [5]. Testosterone's anxiolytic effects may be mediated through its influence on GABAergic systems, serotonin pathways, and the hypothalamic-pituitary-adrenal (HPA) axis, which regulates stress response [6]. Conversely, supraphysiological testosterone levels, often seen with anabolic steroid abuse, can sometimes exacerbate anxiety or lead to irritability and aggression, highlighting the importance of maintaining physiological ranges during TRT [7].

Evidence and Nuances

A systematic review published in Current Opinion in Endocrinology, Diabetes and Obesity concluded that while some studies show an improvement in anxiety symptoms with TRT in hypogonadal men, the evidence is less robust and more heterogeneous compared to depression [8]. The anxiolytic effects might be more pronounced in men with severe hypogonadism and significant baseline anxiety.

TRT and Cognitive Function

Beyond mood, testosterone also plays a role in various aspects of cognitive function, including memory, spatial abilities, and executive function. Low testosterone has been linked to cognitive decline, particularly in older men [9].

Specific Cognitive Domains

Memory: Studies have shown that TRT can improve verbal memory and spatial memory in hypogonadal men [10]. Testosterone influences hippocampal function, a brain region critical for memory formation.

Executive Function: Some research suggests that TRT may enhance executive functions such as attention, planning, and problem-solving, although findings are not entirely consistent across all studies [11].

Processing Speed: Improvements in processing speed have also been observed in some cohorts of hypogonadal men undergoing TRT [12].

Mechanisms of Cognitive Improvement

Testosterone's impact on cognition is multifaceted. It can promote neuronal survival, enhance synaptic plasticity, increase cerebral blood flow, and modulate neurotransmitter systems crucial for cognitive processes [13]. Furthermore, testosterone can be aromatized to estradiol in the brain, which also has significant neuroprotective and cognitive-enhancing effects [14].

Safety Considerations and Contraindications

While TRT can offer significant benefits, it is not without risks and contraindications. A thorough medical evaluation is paramount before initiating treatment.

Potential Side Effects

Erythrocytosis (increased red blood cell count): Can increase the risk of blood clots. Regular monitoring of hematocrit is crucial, and phlebotomy may be required.

Prostate Issues: TRT can exacerbate pre-existing benign prostatic hyperplasia (BPH) symptoms and may accelerate the growth of undetected prostate cancer. It does not cause prostate cancer in healthy men but is contraindicated in men with active prostate cancer [15]. Regular PSA screening is necessary.

Sleep Apnea: TRT can worsen sleep apnea.

Cardiovascular Risk: The relationship between TRT and cardiovascular events is complex and debated. Some studies suggest a potential increased risk in certain vulnerable populations, while others show no increased risk or even a benefit [16]. Careful patient selection and monitoring are essential.

Gynecomastia: Breast tissue enlargement due to increased estrogen levels (from testosterone aromatization). Can be managed with aromatase inhibitors in some cases.

Testicular Atrophy and Infertility: Exogenous testosterone suppresses endogenous testosterone production and spermatogenesis, leading to testicular atrophy and potential infertility. Men desiring fertility should consider alternative treatments or co-administration of hCG [17].

Absolute Contraindications

Active prostate cancer

Active breast cancer

Severe untreated sleep apnea

Uncontrolled heart failure

Hematocrit >50% (prior to correction)

Desire for future fertility (unless co-managed with fertility preservation strategies)

Relative Contraindications/Precautions

Benign prostatic hyperplasia (BPH) with severe lower urinary tract symptoms

Cardiovascular disease (requires careful risk assessment)

History of venous thromboembolism

Key Takeaways

TRT may improve mood and reduce depressive symptoms in men with low testosterone, with robust evidence supporting its role as an adjunctive therapy.

The evidence for TRT as a treatment for anxiety is less clear and requires further investigation, though some anxiolytic effects have been observed in hypogonadal men.

TRT can also positively impact various cognitive functions, including memory and executive function, in men with hypogonadism.

It is essential to consult with a healthcare professional to determine if TRT is an appropriate treatment option, considering individual health status, potential benefits, and risks.

Comprehensive monitoring and patient education are crucial for safe and effective TRT.

References

  • McHenry, J., Carrier, N., Hull, E. M., & Kabbaj, M. (2014). Sex differences in anxiety and depression: role of testosterone. Frontiers in Neuroendocrinology, 35(1), 42-57. [PubMed]
  • Riecher-Rössler, A., & Kulkarni, J. (2015). Estrogens and brain functions. Dialogues in Clinical Neuroscience, 17(4), 435-443. [PubMed]
  • Zarrouf, F. A., Artz, S., Griffith, N. M., Sirbu, C., & Kommor, M. (2009). Testosterone and depression: systematic review and meta-analysis. Journal of Psychiatric Practice, 15(4), 289-305. [PubMed]
  • Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., ... & Yialamas, M. A. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1715-1744. [PubMed]
  • Jackman, S. J., & Majumdar, S. R. (2017). Testosterone and anxiety: a systematic review. Psychoneuroendocrinology, 76, 11-20. [PubMed]
  • Edinger, K. L., & Frye, C. A. (2007). Testosterone's anxiolytic effects in the ventral hippocampus are mediated by 5alpha-reduced metabolites. Pharmacology Biochemistry and Behavior, 86(3), 488-497. [PubMed]
  • Pope Jr, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014). Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocrine Reviews, 35(3), 341-375. [PubMed]
  • Rizvi, A. A. (2018). Testosterone and men's health: a review of the current evidence. Current Opinion in Endocrinology, Diabetes and Obesity, 25(3), 194-200. [PubMed]
  • Hogervorst, E., De Jager, C., Budge, M., & Smith, A. D. (2004). Serum testosterone levels and the risk of Alzheimer disease in men: a meta-analysis. Neurology*, 63(10), 1709-1712. [PubMed]
  • Janowsky, J. S., Chavez, B., & Orwoll, E
  • ---

    Related Articles

  • Anastrozole: Complete Guide
  • Anastrozole: Dosing And Protocols
  • Anastrozole: Evidence-Based Review
  • Anastrozole On Trt: Complete Evidence-Based Guide